There are 2789 resources available
Discussion 4MO, 5MO and 6MO
Presenter: Ruth Plummer
Session: Mini oral session - Basic science
Resources:
Slides
Webcast
Discussion 725MO and 726MO
Presenter: David SP Tan
Session: Mini oral session - Gynaecological cancers
Resources:
Slides
Webcast
Discussion LBA34 and 795MO
Presenter: Naveena Singh
Session: Mini oral session - Gynaecological cancers
Resources:
Slides
Webcast
LBA49 - Efficacy of datopotamab deruxtecan (Dato-DXd) in patients (pts) with advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC) and actionable genomic alterations (AGAs): Preliminary results from the phase I TROPION-PanTumor01 study
Presenter: Edward Garon
Session: Mini oral session - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
829MO - A gene signature to predict risk of transformation in patients with follicular lymphoma
Presenter: Ismael Fernandez-Miranda
Session: Mini oral session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
Introduction by the chair
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Yes
Presenter: Denis Soulieres
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
No
Presenter: Paolo Bossi
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Q&A
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast